After confirming that key markers, such as body and liver weight, as well as lipid profiles in the liver, exhibited similar patterns of hepatic steatosis in both sexes following MOR23 knockout and ligand administration, we chose to focus on a more detailed analysis using male mice as the representative model. The gene discussed is OR10J5; the disease is fatty liver disease.